These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16431338)

  • 1. Pulse steroids: how much is enough?
    Franchin G; Diamond B
    Autoimmun Rev; 2006 Feb; 5(2):111-3. PubMed ID: 16431338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosus.
    Parker BJ; Bruce IN
    Lupus; 2007; 16(6):387-93. PubMed ID: 17664228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylprednisolone in systemic lupus erythematosus.
    Howe HS; Boey ML; Feng PH
    Singapore Med J; 1990 Feb; 31(1):18-21. PubMed ID: 2333537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous pulses of methylprednisolone for systemic lupus erythematosus.
    Badsha H; Edwards CJ
    Semin Arthritis Rheum; 2003 Jun; 32(6):370-7. PubMed ID: 12833245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous systemic lupus erythematosus induced by the therapy for lupus nephritis.
    Jedlickova H; Bohmová J; Sirotkova A
    Int J Dermatol; 2008 Dec; 47(12):1315-6. PubMed ID: 19126028
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monthly pulses of methylprednisolone in SLE nephritis.
    Liebling MR; McLaughlin K; Boonsue S; Kasdin J; Barnett EV
    J Rheumatol; 1982; 9(4):543-8. PubMed ID: 7131454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus.
    Sherer Y; Shoenfeld Y
    Autoimmun Rev; 2006 Feb; 5(2):153-5. PubMed ID: 16431350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors of clinical outcome in patients with diffuse proliferative lupus nephritis treated early by intravenous methylprednisolone pulse therapy.
    Kanno A; Hotta O; Yusa N; Taguma Y
    Ren Fail; 2007; 29(1):41-7. PubMed ID: 17365909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent atrial fibrillation after high-dose methylprednisolone therapy in a girl with lupus-associated hemophagocytic syndrome.
    Yamamura K; Ohga S; Nishiyama K; Doi T; Tsutsumi Y; Ikeda K; Fujishima A; Takada H; Hara T
    Lupus; 2011 Jul; 20(8):871-5. PubMed ID: 21415254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions.
    Ugarte A; Danza A; Ruiz-Irastorza G
    Curr Opin Rheumatol; 2018 Sep; 30(5):482-489. PubMed ID: 29870497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulse methylprednisolone in SLE.
    Kimberly RP
    Clin Rheum Dis; 1982 Apr; 8(1):261-78. PubMed ID: 6749399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sinus bradycardia after intravenous pulse methylprednisolone therapy in patients with systemic lupus erythematosus.
    Ohshima M; Kawahata K; Kanda H; Yamamoto K
    Mod Rheumatol; 2019 Jul; 29(4):700-703. PubMed ID: 28121197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term, high-dose systemic steroids and intraocular pressure.
    Gehlen M; Canto AP; Skare TL; Araújo F; Haider O
    Can J Ophthalmol; 2009 Aug; 44(4):465. PubMed ID: 19606177
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose pulse methylprednisolone for systemic lupus erythematosus flares is efficacious and has a decreased risk of infectious complications.
    Badsha H; Kong KO; Lian TY; Chan SP; Edwards CJ; Chng HH
    Lupus; 2002; 11(8):508-13. PubMed ID: 12220105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravenous cyclophosphamide in lupus nephritis: twenty years reducing dose].
    Frutos MA; Martín Gómez A; de Ramón E; Camps MT; Valera A; García I; Fernández Nebro A
    Nefrologia; 2007; 27(1):12-22. PubMed ID: 17402875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid use and abuse in SLE.
    Ruiz-Irastorza G; Danza A; Khamashta M
    Rheumatology (Oxford); 2012 Jul; 51(7):1145-53. PubMed ID: 22271756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study.
    Tanaka H; Oki E; Tsugawa K; Nonaka K; Suzuki K; Ito E
    Lupus; 2007; 16(11):896-900. PubMed ID: 17971363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic lupus erythematosus presenting with pseudotumor cerebri: a rare association.
    Kuyucu S; Argin A; Kuyucu N; Ozen S
    Turk J Pediatr; 2007; 49(1):98-101. PubMed ID: 17479654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.